Ohnuma, H., Sato, Y., Hayasaka, N., Matsuno, T., Fujita, C., Sato, M., . . . Kato, J. (2018). Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study. Cancer Sci.
استشهاد بنمط شيكاغوOhnuma, Hiroyuki, et al. "Neoadjuvant Chemotherapy With Docetaxel, Nedaplatin, and Fluorouracil for Resectable Esophageal Cancer: A Phase II Study." Cancer Sci 2018.
MLA استشهادOhnuma, Hiroyuki, et al. "Neoadjuvant Chemotherapy With Docetaxel, Nedaplatin, and Fluorouracil for Resectable Esophageal Cancer: A Phase II Study." Cancer Sci 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.